Rhumbline Advisers Boosts Holdings in CME Group Inc. (CME)
Rhumbline Advisers grew its holdings in CME Group Inc. (NASDAQ:CME) by 2.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 661,523 shares of the financial services provider’s stock after acquiring an additional 14,879 shares during the period. Rhumbline Advisers owned about 0.19% of CME Group worth $89,755,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also bought and sold shares of the business. Vanguard Group Inc. grew its stake in shares of CME Group by 2.5% in the second quarter. Vanguard Group Inc. now owns 22,795,894 shares of the financial services provider’s stock worth $2,854,958,000 after acquiring an additional 563,460 shares in the last quarter. Capital International Investors grew its stake in shares of CME Group by 3.3% during the second quarter. Capital International Investors now owns 11,209,987 shares of the financial services provider’s stock worth $1,403,939,000 after purchasing an additional 359,845 shares in the last quarter. Janus Henderson Group PLC grew its stake in shares of CME Group by 13,530.7% during the second quarter. Janus Henderson Group PLC now owns 6,150,016 shares of the financial services provider’s stock worth $770,227,000 after purchasing an additional 6,104,897 shares in the last quarter. Wells Fargo & Company MN grew its stake in shares of CME Group by 25.5% during the second quarter. Wells Fargo & Company MN now owns 4,379,568 shares of the financial services provider’s stock worth $548,496,000 after purchasing an additional 889,217 shares in the last quarter. Finally, Neuberger Berman Group LLC grew its stake in shares of CME Group by 0.5% during the second quarter. Neuberger Berman Group LLC now owns 2,838,544 shares of the financial services provider’s stock worth $355,500,000 after purchasing an additional 14,605 shares in the last quarter. Institutional investors and hedge funds own 82.63% of the company’s stock.
CME has been the subject of a number of analyst reports. BidaskClub upgraded shares of CME Group from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, September 27th. Barclays PLC boosted their target price on shares of CME Group from $139.00 to $149.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 10th. UBS AG reiterated a “buy” rating and set a $135.00 target price (up previously from $134.00) on shares of CME Group in a research note on Wednesday, September 6th. Royal Bank Of Canada boosted their target price on shares of CME Group from $135.00 to $147.00 and gave the stock an “outperform” rating in a research note on Monday, October 16th. Finally, Keefe, Bruyette & Woods reiterated a “hold” rating and set a $127.00 target price on shares of CME Group in a research note on Friday, August 18th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and seven have given a buy rating to the company’s stock. CME Group currently has an average rating of “Buy” and an average price target of $138.89.
In other news, CFO John W. Pietrowicz sold 5,175 shares of the company’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $139.70, for a total value of $722,947.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Daniel R. Glickman sold 850 shares of the company’s stock in a transaction dated Monday, August 28th. The shares were sold at an average price of $126.65, for a total transaction of $107,652.50. Following the completion of the sale, the director now directly owns 13,799 shares of the company’s stock, valued at $1,747,643.35. The disclosure for this sale can be found here. Insiders sold 11,339 shares of company stock valued at $1,548,086 over the last ninety days. Corporate insiders own 0.57% of the company’s stock.
Shares of CME Group Inc. (NASDAQ CME) traded down $0.16 on Monday, reaching $137.88. 750,100 shares of the company were exchanged, compared to its average volume of 1,365,295. CME Group Inc. has a 52-week low of $111.19 and a 52-week high of $141.07. The stock has a market capitalization of $46,757.18, a PE ratio of 28.84, a PEG ratio of 2.82 and a beta of 0.71. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.11.
CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, October 26th. The financial services provider reported $1.19 earnings per share for the quarter, beating analysts’ consensus estimates of $1.16 by $0.03. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The firm had revenue of $890.80 million during the quarter, compared to analysts’ expectations of $890.22 million. During the same period in the previous year, the company earned $1.05 earnings per share. CME Group’s quarterly revenue was up 5.8% compared to the same quarter last year. analysts anticipate that CME Group Inc. will post 4.8 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 27th. Stockholders of record on Friday, December 8th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Thursday, December 7th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 1.91%. CME Group’s payout ratio is 59.86%.
ILLEGAL ACTIVITY WARNING: This news story was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this news story on another website, it was stolen and republished in violation of US and international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.watchlistnews.com/rhumbline-advisers-boosts-holdings-in-cme-group-inc-cme/1700765.html.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.